Colin Moran portfolio, Q1 2026
Abdiel Capital · 13F for the quarter ending Mar 31, 2026
For Q1 2026, Abdiel Capital reported $52M across 5 US-listed positions, led by HCA (68.3%), GLBE (18.6%) and AFRM (11.9%). Compared with its filing for Q4 2025, Colin Moran opened 1 new position, added to 2, reduced 2 and sold out of 3.
The largest purchase was an addition to HCA ($3.7M); the largest sale, the sale of the whole position in Appian Corp ($8.8M).
Key facts
- 13F portfolio value
- $52MQ1 2026
- Positions
- 5
- Largest holding
- HCA 68.3%
- New positions
- 1
- Sold out
- 3
- Filed
- May 15, 2026
Holdings as of (Q1 2026), filed with the SEC on . Changes are measured against the filing for Dec 31, 2025. Every tracked investor's Q1 2026 13F.
Bought and sold in Q1 2026
| Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|
Appian Corpno ticker on file | ▼ Sold out | −248.45K | $8.8M | 16.9% |
| Coupang IncCPNG | ▼ Sold out | −180.97K | $4.3M | 8.20% |
| HCA Healthcare IncHCA | ▲ Added 12% | +7.9K | $3.7M | 7.18% |
| BBB Foods IncTBBB | ▼ Sold out | −48.42K | $1.6M | 3.11% |
| Global-E Online LtdGLBE | ▼ Reduced 12% | −42.22K | $1.3M | 2.50% |
| Navan IncNAVN | ▲ New | +37K | $489.9K | 0.94% |
| Affirm Holdings IncAFRM | ▼ Reduced 6.5% | −9.31K | $426.4K | 0.82% |
Global Business Travel Groupno ticker on file | ▲ Added 18% | +3.24K | $18.1K | 0.03% |
Holdings at the quarter's end
| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Held | Since Q4 2025 |
|---|---|---|---|---|---|---|---|---|
| 1 | HCA Healthcare IncHCA | Health Care | 68.3% | $35.6M | 75.14K | $473.24 | 5 qtrs | ▲ Added 12% |
| 2 | Global-E Online LtdGLBE · SHS | Technology | 18.6% | $9.7M | 314.62K | $30.85 | 8+ qtrs | ▼ Reduced 12% |
| 3 | Affirm Holdings IncAFRM | Financials | 11.9% | $6.2M | 134.74K | $45.82 | 8+ qtrs | ▼ Reduced 6.5% |
| 4 | Navan IncNAVN · CL A | Technology | 0.94% | $489.9K | 37K | $13.24 | 1 qtr | New |
| 5 | Global Business Travel Groupno ticker on file | — | 0.23% | $117.7K | 21.1K | $5.58 | 3 qtrs | ▲ Added 18% |
By sector
| Sector | Share of portfolio | Value | Positions |
|---|---|---|---|
| Health Care | 68.3% | $35.6M | 1 |
| Technology | 19.6% | $10.2M | 2 |
| Financials | 11.9% | $6.2M | 1 |
| No sector on file | 0.23% | $117.7K | 1 |
Questions and answers
What did Colin Moran own in Q1 2026?
Abdiel Capital's 13F for Q1 2026 lists 5 positions worth $52M. The largest: HCA (68.3%), GLBE (18.6%), AFRM (11.9%), NAVN (0.9%), Global Business Travel Group (0.2%).
What did Colin Moran buy in Q1 2026?
The largest purchases, by the shares bought at the quarter-end price the filing implies: HCA (added, $3.7M), NAVN (new, $489.9K), Global Business Travel Group (added, $18.1K).
What did Colin Moran sell in Q1 2026?
The largest sales: Appian Corp (sold out, $8.8M), CPNG (sold out, $4.3M), TBBB (sold out, $1.6M), GLBE (reduced, $1.3M), AFRM (reduced, $426.4K).
When was this filing made?
Abdiel Capital filed its 13F for the quarter ending Mar 31, 2026 on May 15, 2026. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.
Learn
Cite this page
Funkfolio, “Colin Moran portfolio, Q1 2026: Abdiel Capital 13F holdings”, data as of 15 May 2026. https://funkfolio.com/gurus/colin-moran/2026-q1
Underlying data: SEC EDGAR, Form 13F-HR of Abdiel Capital (CIK 1578684) for the period ending Mar 31, 2026.
Source: SEC EDGAR, Form 13F-HR for Abdiel Capital (CIK 1578684), period ending Mar 31, 2026, filed May 15, 2026. Changes compare share counts with the filing for Dec 31, 2025; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $52M reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 8 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. Not a live portfolio and not advice.